PBPierre Bourgoin

Pierre Bourgoin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Pierre Bourgoin has a total of 132 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Long-term health-related quality of life in pediatric ECMO survivors: a prospective controlled study

    by Alexiane Le Helleye, Oscar Werner, Nicolas Joram, Bénédicte Gaillard-Le Roux, Amanda Guerra, Olivier Cadeau, Alexis Chenouard, Arnaud Roy, Alban-Elouen Baruteau, Aurélie Gaultier, et al.

    Extracorporeal membrane oxygenation (ECMO) is associated with neurological complications and potential long-term effects on health-related quality of life (HRQoL), when compared to healthy peers.1 This prospective cross sectional matched case control study evaluated HRQoL, as well as neurodevelopmental, motor and cognitive outcomes in pediatric ECMO survivors. Forty-two ECMO survivors supported with ECMO (2014-2023) were matched with 42 pediatric intensive care unit (PICU) survivors. HRQoL was assessed using the PedsQL 4.0 Generic Core Questionnaire. HRQoL scores were slightly lower in the ECMO group, with a mean adjusted difference for HRQoL total score of -5.4, 95%CI -10.6 to -0.3, p = 0.040. Physical functioning was lower in the ECMO group, with a mean adjusted difference of -9.6, 95%CI -16.8 to -2.5, p = 0.009. Among other outcome measures reported, executive function complaints affected approximately one third of the cohort and were associated with impaired HRQoL. ECMO survivors show minor differences in HRQoL compared with matched PICU survivors except for physical functioning. Both groups demonstrate executive function impairments. ECMO survivors require structured post‑ICU follow‑up to address physical and cognitive needs. ECMO survivors show minor differences compared to matched PICU survivors, except for physical functioning. Both groups have a high rate of executive function impairments during later neuropsychological testing. ECMO survivors should be included in post-ICU follow-up programs. Long-term health-related quality of life in pediatric ECMO survivors: a prospective controlled study.


  • Current use and limitations of direct thrombin inhibitors in pediatric ECMO: A European survey

    by Philippe Gardeton, Nicolas Drillaud, Ariane Willems, Nicolas Joram, Alexis Chenouard, Matteo Di Nardo, Chiara Giorni, Nina Buchtele, Pierre Bourgoin

    Introduction: Direct thrombin inhibitors (DTIs) are an alternative to unfractionated heparin during pediatric ECMO. We aimed to describe their use and limitations across Europe. Methods: Fifty-two pediatric EuroELSO centers were surveyed from July to December 2025. Thirty-seven respondents were analyzed across 11 countries. Results: Most centers (n = 30, 81.1%) were referral sites for pediatric cardiothoracic surgery and 20 (54.1%) also provided non-ECMO mechanical support ( i . e ., ventricular assist devices [VADs]). Seventeen (45.9%) centers reported having used DTIs for the maintenance of systemic anticoagulation during ECMO at least once over the last years. Of these 17 centers, only 3 (17.6%) use DTIs as a first-line anticoagulant for pediatric ECMO. Most centers (n = 11/17, 64.7%) reserve DTIs for specific situations, such as VAD patients or suspected heparin-induced thrombocytopenia. Among the 17 respondents who reported using DTIs, bivalirudin (BIV) was identified as the preferred agent by 16 (94.1%). Dedicated protocols for DTIs management are implemented in 12 (70.6%) out of these 17 centers. Activated partial prothrombin time is the primary assay for monitoring BIV anticoagulation. From the 16 centers using BIV, only 4 (25.0%) reported having specific assays available. The main reported barrier for DTIs implementation was the lack of guidelines and published protocols (n = 14/20, 70.0%). Conclusion: Although recent studies have discussed the interest in DTIs, their adoption as first-line anticoagulant during pediatric ECMO remains limited. Findings from this survey indicate the need for more evidence of DTIs clinical benefit, as well as robust guidelines regarding their protocolized use during pediatric ECMO.

  • Autorégulation cérébrale au cours de la chirurgie cardiaque néonatale et pédiatrique sous circulation extracorporelle

    by Pierre Bourgoin

    Les lésions neurologiques acquises au cours de la chirurgie cardiaque néonatale témoignent pour une majorité d’entre elles de modifications abruptes du débit sanguin cérébral. Au cours de ce travail, nous avons cherché à montrer qu’il était possible de monitorer de manière non-invasive la qualité de l’autorégulation cérébrale (ARC) chez les nouveau-nés et les nourrissons, et d’en dériver des variables d’intérêt : pression de perfusion optimale (MAPopt), limites inférieure et supérieure d’ARC (LLA et ULA). Passée une période de développement du modèle, nous avons mené une série d’études dont l’objectif était de vérifier la possibilité d’identifier MAPopt, LLA et ULA sur un intervalle de temps court (chirurgie), et d’en évaluer la pertinence, à savoir si les valeurs déterminées de manière individuelle étaient associées à la qualité de la perfusion d’organe, en particulier le cerveau.Il existait une perte d’ARC, au cours du départ en CEC. On pouvait déduire du monitorage de l’ARC des valeurs de MAPopt pour environ 80% des patients avant, pendant et après CEC, et en proportion un peu moindre des valeurs de LLA et ULA. Ces valeurs étaient de bons indicateurs d’une perfusion d’organe optimale, pendant la CEC. Le temps passé avec MAP<LLA était la variable la plus fortement associée à la survenue d’une insuffisance rénale, ainsi qu’à la valeur de lactate plasmatique maximale dans les 24h suivant la chirurgie (Publication 1).Chez une cinquantaine de patients, le monitoring a été poursuivi au cours de la surveillance en réanimation. Cette étude à confirmé que la CEC était la période majoritairement associée à une perte d’ARC. La cohorte était dichotomisée en deux groupes de patients, sur la durée de ventilation mécanique post-opératoire, cette valeur étant étroitement associée à la complexité de la chirurgie et au taux de complications post-opératoires. Dans les deux groupes, on notait une récupération post-opératoire d’un statut noram d’ARC, avec toutefois un temps de récupération plus lent et une persistance d’anomalies dans le groupe des patients ventilés plus de 8h. Les valeurs de MAPopt, LLa et ULA mesurées en peropératoire, et au cours de la surveillance post-opératoire, découpée en périodes de 4 heures, étaient superposables (Publication 2, en soumission).Trente-huit nouveau-nés bénéficiant d’une chirurgie cardiaque sous CEC en période néonatale ont été inclus dans l’étude pilote NEMOCARD. Aucun de ces patients n’a présenté d’évènement neurologique clinique (déficit neurologique, convulsion cliniques ou convulsion infraclinique). L’IRM cérébral post opératoire, réalisée au cours du séjour post opératoire avec un délai de 23±16 jours, retrouvait en revanche des lésions silencieuses modérées à sévères chez 17 patients (45%), et 21 (55%) ne présentait aucune lésion ou une lésion mineure. On notait une dysrégulation cérébrale en cours de CEC chez 31/38 (82%) des patients, sans qu’il soit possible d’identifier de variable explicative dans cet effectif. On identifait une LLA et une ULA égale à 42.4±8.6 et 58.2±9.5 mmHg, respectivement, au cours de la CEC. La saturation régionale cérébrale était identique dans les deux groupes, de même que la pression artérielle moyenne, mais la LLA et le temps passé en dessous de la LLA était plus élevé dans le groupe présentant des lésions neurologiques par rapport au groupe sans lésions neurologique (Publication n°3).Le monitoring de MAPOPT, LLA et ULA est possible dans une population de nouveau-nés et nourrissons au cours de la chirurgie cardiaque sous CEC, et nous avons pu déterminer une pertinence à la proposer. Ces données seront vérifiées dans une étude de validation externe de plus grand effectif, qui permettra de tenir compte de pratiques de CEC variables. Compte tenu de la fréquence des lésions acquises après CEC, les évènements périopératoires doivent être intégrés aux modèles de prédiction d’anomalies neurodeveloppemementales après chirurgie cardiaque néonatale.

  • Tele-Proctoring for Device Closure of Patent Ductus Arteriosus in Extremely Low-Birth-Weight Infants

    by Alban-Elouen Baruteau, Gérald Laforest, Jean-Bernard Selly, Nadir Benbrik, Pierre Bourgoin, Yael Levy

  • Open Access

    Long-term health-related quality of life in pediatric ECMO survivors: a prospective controlled study

    by Alexiane Le Hellaye, Oscar Werner, Nicolas Joram, B Gaillard Le Roux, Amanda Guerra, Olivier Cadeau, Alexis Chenouard, Arnaud Roy, Alban-Elouen Baruteau, Aurelie Gaultier, et al.

    Introduction: Extracorporeal Membrane Oxygenation (ECMO) is an intervention used for neonates, infants, and children with severe respiratory or cardiac failure. While ECMO has been linked to improved survival rates, it is also associated with neurological complications and potential long-term effects on health-related quality of life (HRQoL), when compared to healthy peers. In order to better characterize the longer-term outcomes of ECMO itself, this study evaluated HRQoL, as well as neurodevelopmental, motor, and cognitive outcomes in pediatric ECMO survivors in comparison to a matched control group. Methods: We conducted a prospective cross-sectional matched case-control study at Nantes University Hospital, France. Forty-two ECMO survivors supported with ECMO from January 2014 to January 2023 were matched with 42 pediatric intensive care unit (PICU) survivors. HRQoL was assessed using the PedsQL 4.0 Generic Core Questionnaire. Neurodevelopmental outcomes were evaluated with the Age and Stage Questionnaire (ASQ) or the Strengths and Difficulties Questionnaire (SDQ), motor function with the Global Motor Function Classification Score (GMFCS), and executive functioning with the Behavior Rating Inventory of Executive Function (BRIEF). Results: Overall HRQoL scores were slightly lower in the ECMO group, with a mean adjusted difference for HRQoL total score of -5.4, 95%CI -10.6 to -0.3, p=0.040 . Notably, physical functioning was lower in the ECMO group, with a mean adjusted difference of -9.6, 95%CI -16.8 to -2.5, p=0.009 . Amongother outcome measures reported, executive function complaints affected approximately one thirds of the cohort and were associated with impaired HRQoL. Among other variables tested, parental stress index and parental level of education were also associated with HRQoL total score or subdomains. Conclusion: ECMO survivors often experience slight changes in their health-related quality of life as compared with a matched control cohort, particularly in physical functioning. This study also identifies cognitive and executive functioning impairments that may persist long after discharge from the PICU.

  • Clinical research study: cerebral autoregulation in neonates and infants undergoing open heart surgery: global patterns and derived cerebral hemodynamic metrics

    by Pierre Bourgoin, Erta Beqiri, Peter Smielewski, Ariane De Windt, Remi Bernardon, Guillaume Emeriaud, Ugo Gouedard, Alban Baruteau, Alexis Chenouard, Nicolas Joram, et al.

    Background Optimal perfusion pressure targets during cardiopulmonary bypass in children are debated. Monitoring of CAR allow determination of optimal perfusion pressures, but its feasibility within a large cohort of children warrants further investigations. Methods Prospective, single center, observational study. Cerebral Oxygenation Index (COx) was calculated as a moving linear correlation coefficient between slow waves of mean arterial pressure (MAP) and cerebral oxygenation saturation. Postoperative outcomes were recorded and associations with CAR derived metrics were explored. Results Mean COx values demonstrated CAR disruption during CPB (0.17 ± 0.17 before vs. 0.36 ± 0.13 during, p < 0.001). Post-CPB, CAR restored partially (mean Cox 0.32 ± 0.16, p < 0.05). Factors associated with CAR Disruption were age at surgery and average hematocrit during CPB. MAPopt determination was feasible in 83.3%, 75.4%, and 67.5% of patients before, during, and after surgery, respectively. LLA was determined in 78.1%, 53.5%, and 56.1%, and ULA in 71%, 50%, and 57% during the same time frames. Dose of MAP below LLA during CPB was independently associated with pre-postoperative serum creatinine ratio and 24 h postoperative serum lactate levels. Conclusions The findings highlight the clinical significance of CAR monitoring, with implications for optimizing cerebral and systemic perfusion in this vulnerable population. Impact In most cases, cardiopulmonary bypass is associated with CAR disruption, highlighting the need for rigorous perfusion pressure management. Individualized determination of optimal MAP target is feasible in neonates and infants undergoing cardiopulmonary bypass using CAR-derived metrics. The time spent within a range of optimal pressure is associated with better body perfusion. Live determination of optimal MAP may be used to develop individualized PAM management interventions, and ultimately improve body perfusion including the brain.


  • Perioperative Factors Associated with 2-Year Neurodevelopmental Outcome in Neonates Undergoing Congenital Cardiac Surgery with Cardiopulmonary Bypass: A Single-Center Cohort Study

    by Florence Mycinski, Oscar Werner, Alban-Elouen Baruteau, Benedicte Gaillard- Le Roux, Cyril Flamant, Valérie Rouger, Nicolas Joram, Alexis Chenouard, Pierre Bourgoin

    Advances in neonatal cardiac surgery have significantly reduced mortality rates for complex congenital heart diseases (CHD). However, long-term morbidities, particularly neurodevelopmental (NDV) outcomes, remain a concern. Perioperative factors implicated in NDV delays are less described. This study aimed to assess NDV outcomes at 2 years in a cohort of neonates undergoing cardiopulmonary bypass (CPB) and identify perioperative variables associated with non-optimal NDV. This analysis included neonates from the Loire Infant Follow-up Team (LIFT) cohort who underwent CPB between 2014 and 2021. NDV outcomes were assessed at 24 months using the Ages and Stages Questionnaire (ASQ-2) and/or expert clinical evaluations. Non-optimal NDV was defined as two or more ASQ domains below cut-off values or a clinical diagnosis of neurodevelopmental delay. Of 254 neonates operated on 84 were analyzed. Non-optimal NDV was observed in 11 patients (13.1%), while 65 (77.4%) were classified as having Optimal NDV. Motor and cognitive delays were infrequent (5%), and language delays were observed in 9.5% of cases. No association between major complication during post-operative period and non-optimal NDV was found. Maximal serum lactate levels during the first 72 postoperative hours were significantly associated with non-optimal NDV after adjusting for RACHS category (adjusted odds ratio: 1.41 per mmol/L above 2.2 mmol/L, p = 0.04). Contemporary neonatal cardiac surgery shows encouraging NDV outcomes, with achieving normal development by 2 years. Elevated postoperative lactate levels, used as a surrogate of serious events occurring during the post-operative period, were associated with non-optimal NDV, highlighting the importance of optimizing perioperative care. Larger studies with extended follow-up are needed to validate these findings and explore additional modifiable predictors of long-term outcomes.


  • Characteristics and outcomes of children and young adults with sickle cell disease supported with extracorporeal membrane oxygenation (ECMO): An updated analysis of the ELSO registry

    by Tancrède Remy, Julien Jegard, Alexis Chenouard, Pierre Maminirina, Jean Michel Liet, Marie‐Laure Couec, Nicolas Joram, Pierre Bourgoin

    Background: Sickle cell disease (SCD) is a global hemoglobinopathy; approximately 300 000 individuals are diagnosed annually. Acute chest syndrome (ACS), a common complication, leads to significant hospitalization and mortality, particularly in cases of severe respiratory distress. ECMO outcomes in this specific population are poorly described.Methods: This retrospective observational study, utilizing data from the Extracorporeal Life Support Organization (ELSO) registry, focuses on children and young adults (<40 years) with SCD undergoing ECMO from 1998 to 2022.Results: We observed a growing trend in ECMO cases over the last 15 years, with 210 SCD patients identified in the registry (five neonates, 95 children, 110 adults). ECMO was predominantly initiated for pulmonary support (62%), and most of the primary diagnoses were related to SCD (reported as “SCD” or “acute chest syndrome”). The global survival rate was 55.8% (59% for children and 52.7% for adults). None of the children supported for extracorporeal cardiopulmonary resuscitation survived, and only 2/18 (11%) of adults cannulated for ECPR survived. Complication rates, including acute renal failure (33.8%) neurological events (13%), thrombotic (23.3%), or bleeding events (22.9%) were not noticeably different from reported outcomes in the ELSO registry.Conclusion: Our findings suggest that ECMO outcomes in SCD patients align with general ECMO trends and may not be limited by suspected unfavorable results in children and young adults. Despite limitations, our study contributes valuable insights into using ECMO in SCD, emphasizing the need for further research and understanding in this underexplored domain.


  • Red Blood Cell Transfusion Requirements Before and After Implementation of a Perioperative Patient Blood Management Program in Adult Patients Undergoing Cardiac Surgery. A Before and After Observational Study

    by Jeremie Czarnecka, Arthur Neuschwander, Thomas Aujoulat, Adrien Balmier, Dominique Belcour, Boris Boulanger, Caroline Bourgain, Margot Caron, Gabor Kiss, Mathilde Larghi, et al.